Published online September 30, 2005
PEDIATRICS Vol. 116 No. 4 October 2005, pp. 862-871 (doi:10.1542/peds.2004-2571)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Botkin, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Botkin, J. R.
Related Collections
Right arrow Office Practice

Research for Newborn Screening: Developing a National Framework

Jeffrey R. Botkin, MD, MPH

Department of Pediatrics and Medical Ethics, University of Utah, Salt Lake City, Utah

Newborn metabolic screening represents the largest application of genetic testing in medicine. As new technologies are developed, the number of conditions amenable to newborn screening (NBS) will continue to expand. Despite the scope of these programs, the evidence base for a number of NBS applications remains relatively weak. This article briefly reviews the evidence base for several conditions. The article then develops a proposal for a structured sequence of research protocols to evaluate potential applications for NBS before their formal implementation in public health programs. Such a framework for research will require collaboration between states and the federal government, a collaboration that is emerging through recent federal legislation and funding.

Key Words: newborn screening • ethics • research

Abbreviations: NBS, newborn screening • PKU, phenylketonuria • MCAD, medium-chain acyl-coenzyme A dehydrogenase deficiency • MS/MS, tandem mass spectrometry • RCT, randomized, controlled trial • SCD, sickle cell disease • CF, cystic fibrosis

Accepted Jan 12, 2005.




This article has been cited by other articles:


Home page
 J Pediatr PsycholHome page
D. B. Bailey Jr, F. D. Armstrong, A. R. Kemper, D. Skinner, and S. F. Warren
Supporting Family Adaptation to Presymptomatic and "Untreatable" Conditions in an Era of Expanded Newborn Screening
J. Pediatr. Psychol., March 30, 2008; (2008) jsn032v1.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. E. Waisbren
Newborn screening for metabolic disorders.
JAMA, August 23, 2006; 296(8): 993 - 995.
[Full Text] [PDF]

Home page
 PediatricsHome page
B. A. Tarini, D. A. Christakis, and H. G. Welch
State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results
Pediatrics, August 1, 2006; 118(2): 448 - 456.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. Koopmans and L. F. Ross
Does Familiarity Breed Acceptance? The Influence of Policy on Physicians' Attitudes Toward Newborn Screening Programs
Pediatrics, May 1, 2006; 117(5): 1477 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. R. Botkin, E. W. Clayton, N. C. Fost, W. Burke, T. H. Murray, M. A. Baily, B. Wilfond, A. Berg, and L. F. Ross
Newborn Screening Technology: Proceed With Caution
Pediatrics, May 1, 2006; 117(5): 1793 - 1799.
[Full Text] [PDF]

Home page
 PediatricsHome page
P. J. Pivalizza
Research for Newborn Screening: Developing a National Framework
Pediatrics, May 1, 2006; 117(5): 1869 - 1869.
[Full Text] [PDF]